Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-08-09
2005-08-09
Carlson, Karen Cochrane (Department: 1653)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S011400, C530S402000, C530S317000
Reexamination Certificate
active
06927208
ABSTRACT:
The invention relates to a novel cyclosporin, the pharmaceutical use thereof and a pharmaceutical composition containing it.
REFERENCES:
patent: 4108985 (1978-08-01), Rüegger et al.
patent: 4210581 (1980-07-01), Rüegger et al.
patent: 4220641 (1980-09-01), Traber et al.
patent: 4288431 (1981-09-01), Traber et al.
patent: 4396542 (1983-08-01), Wenger
patent: 4441644 (1984-04-01), Farian
patent: 4554351 (1985-11-01), Wenger
patent: 4814323 (1989-03-01), Andrieu et al.
patent: 5767069 (1998-06-01), Ko et al.
patent: 5948884 (1999-09-01), Lüchinger
patent: 6444643 (2002-09-01), Steiner et al.
patent: 0 484 281 (1992-05-01), None
patent: 0484281 (1992-06-01), None
patent: WO 97 04005 (1997-06-01), None
Holmes, K. K. et al. (1996) “report of the NIH AIDS research program evaluation” pp. 1-40.
S. O'Keefe et al., FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin, Nature, vol. 357, pp. 692-694, 1992.
Papageorgiou C et al: “Anti HIV-1 Activity of a Hydrophilic Cyclosporin Derivative with improved Binding Affinity to Cyclophilin A” Bioorganic & Medicinal Chemistry Letters, vol. 6, No. 1, 1996, pp. 23-26, 497, XP000615812.
Mutter Manfred
Ruckle Thomas
Wenger Roland M.
Carlson Karen Cochrane
Debiopharm S.A.
Liu Samuel W.
Sturm & Fix LLP
LandOfFree
Cyclosporin with improved activity profile does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclosporin with improved activity profile, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclosporin with improved activity profile will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3519162